Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +16.7% | +53.8% | 3 / 3 | +6.9% | +0.76 pp | +0.91 pp | +9.7% | 0.00 | 15.28 | 53,6 | +6,9% | 5,8 | +16,7% | 15.28 | 27.65 | −44,8% |
| Pts | 0 | 12 | 12 | 0 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 16.000 (close price on 2026-10-09)EPS (TTM): 1.047
Financial charts
1.Revenue & growth
VND bn53,6Q2/26
1.Revenue & growth
VND bn53,6Q2/26
2.Profit & growth
VND bn5,81Q2/26
3.Profit mix (Penman)
VND bn25,6Q2/26
4.Margins & cost structure
%43.2%Q2/26
5.Returns & cash cycle
% · days14.6%Q2/26
6.Earnings quality & cash
VND bn40,4Q2/26
7.Asset structure
VND bn235Q2/26
8.Funding & debt health
VND bn · times235Q2/26
9.Revenue backlog
VND bn0,03Q2/26
10.Valuation
times · %15,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %320Q2/26
Adjusted EPS growth, latest quarter
16.7%
Average adjusted EPS growth, 3 quarters
53.8%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26